# Pericardial Diffuse Large B-Cell Lymphoma Diagnosed Via Computed Tomography–Guided Biopsy

**Authors:** Toshiya Yoshida, Midori Nanamatsu, Shunichi Asano, Takuya Narita, Miki Terauchi, Akira Hirasawa, Yukio Kakuta, Kazuhiko Yumoto

PMC · DOI: 10.1016/j.jaccas.2025.105070 · JACC Case Reports · 2025-09-24

## TL;DR

A rare case of pericardial lymphoma was successfully diagnosed using CT-guided biopsy, avoiding complications and enabling effective treatment.

## Contribution

Demonstrates the effectiveness of CT-guided biopsy for diagnosing pericardial lymphoma in complex cases.

## Key findings

- CT-guided biopsy confirmed pericardial diffuse large B-cell lymphoma without complications.
- Multidisciplinary discussion was critical in selecting the safest diagnostic approach.
- Treatment with targeted therapy led to tumor shrinkage.

## Abstract

Primary pericardial lymphomas are rare. We describe a case of pericardial diffuse large B-cell lymphoma (DLBCL) diagnosed via computed tomography (CT)–guided biopsy.

A 57-year-old man presented with chest pain and weight loss for 1 month. Multiple diagnostic modalities revealed a pericardial mass with effusion. Pericardiocentesis was performed, and cytology suggested malignant lymphoma; however, the procedure was complicated by pneumothorax owing to mediastinal distortion from the pectus excavatum and minimal effusion. After multidisciplinary discussion, CT-guided biopsy was performed, which confirmed DLBCL. Polatuzumab vedotin, rituximab/cyclophosphamide, doxorubicin, and prednisone were initiated, resulting in tumor shrinkage.

Early histopathological diagnosis is essential for treating malignant lymphoma. In this case, CT-guided biopsy was selected as the safest and most effective approach and was successfully performed without complications.

A multidisciplinary approach is necessary for early diagnosis of pericardial lymphoma. CT-guided biopsy can be effective in certain cases.

## Linked entities

- **Chemicals:** doxorubicin (PubChem CID 31703), prednisone (PubChem CID 5865)
- **Diseases:** diffuse large B-cell lymphoma (MONDO:0018905), pneumothorax (MONDO:0002076), pectus excavatum (MONDO:0008213)

## Full-text entities

- **Diseases:** pneumothorax (MESH:D011030), pericardial mass (MESH:C536030), Primary pericardial lymphomas (MESH:D008223), DLBCL (MESH:D016403), effusion (MESH:D000080324), tumor (MESH:D009369), pectus excavatum (MESH:D005660), chest pain (MESH:D002637), weight loss (MESH:D015431)
- **Chemicals:** prednisone (MESH:D011241), rituximab (MESH:D000069283), doxorubicin (MESH:D004317), cyclophosphamide (MESH:D003520), Polatuzumab vedotin (MESH:C000600736)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12539431/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12539431/full.md

## References

10 references — full list in the complete paper: https://tomesphere.com/paper/PMC12539431/full.md

---
Source: https://tomesphere.com/paper/PMC12539431